Candida auris Isolates Resistant to Three Classes of Antifungal Medications --- New York, 2019
by from Morbidity and Mortality Weekly Report (MMWR) on (#4XP1D)
Although rare, Candida auris resistant to all three classes of commonly used antifungal drugs was identified in three patients in New York. CDC considers C. auris an urgent threat, the highest category of concern.